Table 4 Change in diabetic medication management stratified by Pre-SiP HbA1c categories
Treatment | Total group | HbA1c (< 7%) | HbA1c (7-7.9%) | HbA1c (8-8.9%) | HbA1c (9-9.9%) | HbA1c (≥ 10) |
|---|---|---|---|---|---|---|
Discontinuation of oral hypoglycemic | 3.06 | 2.97 | 2.32 | 2.99 | 3.98 | 6.11 |
New use of oral hypoglycemic | 3.42 | 3.04 | 3.74 | 2.68 | 3.50 | 5.91 |
Net increase/decrease in OHA use | 0.36 | 0.07 | 1.42 | -0.31 | -0.48 | -0.20 |
Discontinuation of insulin | 1.64 | 1.04 | 1.42 | 2.02 | 2.83 | 4.58 |
New use of insulin | 2.24 | 1.00 | 1.90 | 3.20 | 4.47 | 7.77 |
Net increase/decrease in insulin use | 0.60 | -0.04 | 0.48 | 1.18 | 1.64 | 3.19 |